Models
ANUH PHARMA LIMITEDANUHPHRPharmaceuticals & Biotechnology
24per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model24implied FY26 P/E 4.5× · EV/EBITDA 3.7×
Against CMP ₹95.0075.0%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3172%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
1934
52-week rangetraded range, a fact not a value
67100

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow63
PV of terminal value166
Enterprise value230
less net debt8
less non-controlling interest0
add non-operating investments0
Equity value238
÷ 10.02 crore shares24

Free cash flow, filed and modelled · ₹ '000 crore

000000FY21: ₹(25) croreFY21FY22: ₹27 croreFY22FY23: ₹52 croreFY23FY24: ₹8 croreFY24FY25: ₹17 croreFY25FY26: ₹(11) croreFY26FY27: ₹16 croreFY27FY28: ₹16 croreFY28FY29: ₹17 croreFY29FY30: ₹17 croreFY30FY31: ₹16 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%2426283134
10.50%2324262830
11.00%2122242527
11.50%2021222325
12.00%1920212223
The outlined cell is your model. Green figures sit above the CMP of ₹95.00; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P102P5024P9041
10th · 50th · 90th percentile, ₹ per share2 · 24 · 41
Draws below the CMP100%
Rank correlation with revenue growth0.70
Rank correlation with ebitda margin+0.68
Rank correlation with discount rate0.12
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue5276476627728991,0471,2201,4211,656
growth %8.422.72.216.716.516.516.516.516.5
EBITDA51756162728498114132
margin %9.711.69.28.08.08.08.08.08.0
less depreciation(10)(9)(9)(11)(13)(16)(18)(21)(25)
EBIT4267525058687992108
less tax on EBIT(12)(14)(17)(19)(22)(26)
NOPAT384452607081
add depreciation1099111316182125
less capex(2)(5)(20)(8)(9)(13)(17)(23)(30)
less working-capital build(33)(38)(45)(52)(61)
Free cash flow to firm528171616171716
Discount factor0.9490.8550.7700.6940.625
Present value1514131210
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 0, dividends at 36.5% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT5058687992108
Interest at 9% on debt00000
Profit before tax58687992108
Profit after tax414452607081
Dividends(15)(16)(19)(22)(26)(30)
Balance sheet, year end
Cash8850(9)(23)
Working capital199232270314366427
Net block and other assets351346343342343348
Debt000000
Equity352380413451496547
Balance check0(0)0000
Cash flow
From operations2529343946
Investing (capex)(9)(13)(17)(23)(30)
Financing (dividends)(16)(19)(22)(26)(30)
Net change in cash(0)(2)(5)(9)(14)
Free cash flow to equity1616171716
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF16.5%8%11.00%5%24(75.0)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.